Aveanna Healthcare - AVAH Stock Forecast, Price & News

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aveanna Healthcare in the last year. There are currently 1 sell rating, 5 hold ratings, 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AVAH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AVAH, but not buy additional shares or sell existing shares.
View AVAH analyst ratings or view top-rated stocks.

9 equities research analysts have issued 1-year price targets for Aveanna Healthcare's shares. Their AVAH share price forecasts range from $1.25 to $6.00. On average, they predict the company's stock price to reach $3.25 in the next year. This suggests a possible upside of 330.3% from the stock's current price.
View analysts price targets for AVAH or view top-rated stocks among Wall Street analysts.

Aveanna Healthcare's stock was trading at $7.40 on January 1st, 2022. Since then, AVAH stock has decreased by 89.8% and is now trading at $0.7552.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, March 27th 2023.
View our AVAH earnings forecast.

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) posted its quarterly earnings data on Wednesday, November, 9th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.04 by $0.07. The business had revenue of $443.01 million for the quarter, compared to analysts' expectations of $448.84 million. Aveanna Healthcare had a positive trailing twelve-month return on equity of 6.05% and a negative net margin of 31.44%.

Aveanna Healthcare issued an update on its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.78B-, compared to the consensus revenue estimate of $1.80 billion.

(AVAH) raised $478 million in an initial public offering on Thursday, April 29th 2021. The company issued 38,200,000 shares at a price of $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse served as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers.

Aveanna Healthcare trades on the NASDAQ under the ticker symbol "AVAH."

Aveanna Healthcare's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vaughan Nelson Investment Management L.P. (2.70%), Littlejohn & Co. LLC (2.23%), Vanguard Group Inc. (1.83%), BlackRock Inc. (1.75%), LGT Capital Partners LTD. (0.91%) and Putnam Investments LLC (0.64%). Insiders that own company stock include David Afshar, Jeff Shaner, Patrick A Cunningham, Steven E Rodgers and Tony Strange.
View institutional ownership trends.

Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AVAH stock can currently be purchased for approximately $0.76.

Aveanna Healthcare (NASDAQ:AVAH) has a market capitalization of $140.41 million and generates $1.68 billion in revenue each year. The company earns $-117,040,000.00 in net income (profit) each year or ($2.97) on an earnings per share basis.

The company employs 33,000 workers across the globe.

Aveanna Healthcare's mailing address is 400 INTERSTATE NORTH PARKWAY STE 1700, ATLANTA GA, 30339. The official website for the company is www.aveanna.com. The company can be reached via phone at 770-441-1580 or via email at ir@aveanna.com.